Royal Bank of Canada raised its target price and gave an outperform rating for Globus Medical. Needham & Company also increased its target price and gave a buy rating.
2 reports, 1 independent
Updated Aug 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada raised its target price and gave an outperform rating for Globus Medical. Needham & Company also increased its target price and gave a buy rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Globus Medical
company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
-
Needham & Company
American independent investment bank and asset management firm
Related events
- Royal Bank of Canada, Goldman Sachs, and Needham issued updated price targets and ratings for various companies.
- Royal Bank of Canada upped its target price for Citizens Financial Group.
- Royal Bank of Canada raised its target price for DCH.
- Royal Bank of Canada, Citigroup, and Morgan Stanley issued price target and rating updates on August 27, 2026.
- Royal Bank of Canada raised its price target for TMX Group.